| MEN1 mutations mediate clinical resistance to menin inhibition F Perner, EM Stein, DV Wenge, S Singh, J Kim, A Apazidis, ... Nature 615 (7954), 913-919, 2023 | 57 | 2023 |
| MN1–Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells DV Wenge, E Felipe-Fumero, L Angenendt, C Schliemann, E Schmidt, ... Oncogenesis 4 (12), e179-e179, 2015 | 13 | 2015 |
| Blinatumomab or inotuzumab ozogamicin as bridge to allogeneic stem cell transplantation for relapsed or refractory B-lineage acute lymphoblastic leukemia: a retrospective … P Stelmach, K Wethmar, C Groth, DV Wenge, J Albring, JH Mikesch, ... Clinical Lymphoma Myeloma and Leukemia 20 (10), e724-e733, 2020 | 7 | 2020 |
| Characteristics and outcome of elderly patients (> 55 years) with acute lymphoblastic leukemia DV Wenge, K Wethmar, CA Klar, H Kolve, T Sauer, L Angenendt, G Evers, ... Cancers 14 (3), 565, 2022 | 6 | 2022 |
| Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML W Bourgeois, JA Cutler, BJ Aubrey, DV Wenge, F Perner, C Martucci, ... Blood 143 (15), 1513-1527, 2024 | 3 | 2024 |
| The future of HOXA-expressing leukemias: Menin inhibitor response and resistance DV Wenge, SA Armstrong Current Opinion in Hematology 31 (2), 64-70, 2024 | 1 | 2024 |
| Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia N Tubío-Santamaría, AK Jayavelu, TM Schnoeder, T Eifert, CJ Hsu, ... Molecular Cancer 22 (1), 196, 2023 | 1 | 2023 |
| S125: NON-GENETIC RESISTANCE TO MENIN INHIBITION IN AML IS REVERSIBLE BY PERTURBATION OF KAT6A F Perner, H Rahnamoun, DV Wenge, Y Xiong, A Apazidis, D Anand, ... HemaSphere 7, e6233123, 2023 | 1 | 2023 |
| High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts AB Schulze, DV Wenge, G Evers, B Heitkötter, A Bleckmann, LH Schmidt, ... Translational Lung Cancer Research 12 (4), 727, 2023 | 1 | 2023 |
| Characterization of acquired resistance mutations to menin inhibitors F Perner, SF Cai, DV Wenge, J Kim, J Cutler, RP Nowak, J Cassel, ... Cancer Research 83 (7_Supplement), 3457-3457, 2023 | 1 | 2023 |
| Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy DV Wenge, K Wethmar, JH Mikesch, C Reicherts, C Schliemann, ... Leukemia & Lymphoma 62 (8), 1930-1939, 2021 | 1 | 2021 |
| Menin Inhibitor Induced Menin Protein Degradation Contributes to Menin Inhibitor Efficacy J Cutler, J Tsai, B Regalado, W Bourgeois, D Wenge, J Kim, R Nowak, ... Blood 142, 2788, 2023 | | 2023 |
| 2012–IMMUNOPROTEASOME FUNCTION MAINTAINS ONCOGENIC GENE EXPRESSION IN KMT2A-COMPLEX DRIVEN LEUKEMIA F Heidel, N Tubio-Santamaria, AK Jayavelu, T Schnoeder, T Eifert, ... Experimental Hematology 124, S42, 2023 | | 2023 |
| Characteristics and Outcome of Elderly Patients (> 55 Years) with Acute Lymphoblastic Leukemia (ALL) DV Wenge, K Wethmar, C Klar, H Kolve, T Sauer, L Angenendt, G Evers, ... Blood 138, 3365, 2021 | | 2021 |
| Transformation muriner hämatopoetischer Progenitorzellen in Zellen einer akuten megakaryoblastären Leukämie durch das Fusionsonkogen MN1-FLI1 DV Wenge Westfälische Wilhelms-Universität Münster, 2020 | | 2020 |
| Allogeneic HSCT in therapy-associated AML and MDS after treatment for lymphoma: A retrospective single-center analysis DV Wenge, C Reicherts, JH Mikesch, C Groth, K Wethmar, C Schliemann, ... BONE MARROW TRANSPLANTATION 54, 165-166, 2019 | | 2019 |
| Delay of consolidation chemotherapy indicates an independent risk factor in older patients (>= 60 years) with acute myeloid leukemia-a retrospective single-center analysis DV Wenge, L Angenendt, U Krug, M Stelljes, WE Berdel, G Lenz, ... ONCOLOGY RESEARCH AND TREATMENT 41, 56-56, 2018 | | 2018 |
| MN1-Fli1 oncofusion transforms hematopoietic stem cells into acute megakaryoblastic leukemia cells D Wenge, FE Fumero, L Angenendt, C Schliemann, E Schmidt, ... Oncology Research and Treatment 38, 214-215, 2015 | | 2015 |
